尼羅替尼及其中間體
中文名稱:尼羅替尼及其中間體中文別名:4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲醯胺;尼羅替尼;尼羅替尼及其中間體(研發);4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲醯胺
英文名稱:Nilotinib & its intermediates
英文別名:Nilotinib; AMN 107; Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-; 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide Nilotinib(TINIBS ); Nilotinib for research; Tasigna; Nilotinib & its intermediates (Developing); Nilotinib, AMN107, Tasigna; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide
CAS:641571-10-0
分子式:C28H22F3N7O
分子量:529.5158
